Weekly Rundown: Genentech partners with Caris Life Sciences in $1.1B deal Investments in solid tumor targets and autoimmune disease, success for a peanut allergy patch, a promising CAR T cell therapy for stiff person syndrome, and more led the news this week.
No hay comentarios:
Publicar un comentario